Enliven Therapeutics, Inc. (ELVN)
54.32
-1.91
(-3.40%)
USD |
NASDAQ |
Sep 11, 16:00
54.29
-0.03
(-0.06%)
After-Hours: 20:00
Enliven Therapeutics Total Assets (Quarterly) : 910.22M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 910.22M |
| March 31, 2026 | 464.85M |
| December 31, 2025 | 476.28M |
| September 30, 2025 | 490.88M |
| June 30, 2025 | 503.89M |
| March 31, 2025 | 302.57M |
| December 31, 2024 | 325.76M |
| September 30, 2024 | 305.43M |
| June 30, 2024 | 327.04M |
| March 31, 2024 | 342.78M |
| December 31, 2023 | 271.87M |
| September 30, 2023 | 274.04M |
| June 30, 2023 | 288.50M |
| March 31, 2023 | 302.87M |
| Date | Value |
|---|---|
| December 31, 2022 | 91.96M |
| September 30, 2022 | 59.10M |
| June 30, 2022 | 64.67M |
| March 31, 2022 | 81.60M |
| December 31, 2021 | 93.65M |
| September 30, 2021 | 107.03M |
| June 30, 2021 | 72.47M |
| March 31, 2021 | 81.69M |
| December 31, 2020 | 90.84M |
| September 30, 2020 | 100.18M |
| June 30, 2020 | 111.32M |
| March 31, 2020 | 110.32M |
| December 31, 2019 | 33.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.07M |
| Shareholders Equity (Quarterly) | 895.15M |
| Debt to Equity Ratio | 0.0017 |
| Current Ratio | 64.07 |
| Net Debt Paydown Yield | -0.01% |